Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancer

16Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.

Abstract

Capan-1 is a well-characterised BRCA2-deficient human cell line isolated from a liver metastasis of a pancreatic adenocarcinoma. Here we report a genome-wide assessment of structural variations and high-depth exome characterization of single nucleotide variants and small insertion/deletions in Capan-1. To identify potential somatic and tumour-associated variations in the absence of a matched-normal cell line, we devised a novel method based on the analysis of HapMap samples. We demonstrate that Capan-1 has one of the most rearranged genomes sequenced to date. Furthermore, small insertions and deletions are detected more frequently in the context of short sequence repeats than in other genomes. We also identify a number of novel mutations that may represent genetic changes that have contributed to tumour progression. These data provide insight into the genomic effects of loss of BRCA2 function. © 2011 Barber et al.

Cite

CITATION STYLE

APA

Barber, L. J., Rosa, J. M. R., Kozarewa, I., Fenwick, K., Assiotis, I., Mitsopoulos, C., … Ashworth, A. (2011). Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancer. PLoS ONE, 6(7). https://doi.org/10.1371/journal.pone.0021639

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free